RxDoctor Payments Data

Christa Setser

Psychiatric/Mental Health · Clintwood, VANPI 1659980373

Payments from drug & device makers

$3,885in general payments, 2019–2025

Across 202 payments — averaging $19.23 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.

  • AbbVie$739
  • Neurocrine Biosciences, Inc.$653
  • Otsuka America Pharmaceutical, Inc.$438
  • Axsome Therapeutics, Inc.$390
  • ITI, Inc. (d/b/a Intra-cellular Therapies, Inc.)$329
  • Teva Pharmaceuticals USA, Inc.$313
  • plus $1K from 11 others

What the payments were for

  • Food & beverage$3,83899%
  • Education$471%

Most of this is food and beverage — typically meals provided during product presentations at a clinic or hospital. Nationally that is the single largest category of reported payments by count.

General payments by program year

21
22
23
24
25

Who reported the general payments

Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.

What the payments were tied to

Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.

How this compares

$3,885 in reported general payments places this provider in the 85th percentile of 1,003 psychiatric/mental health providers in Virginia.

See all psychiatric/mental health providers in Virginia

Most prescribed under Part D

DrugClaimsCost to plans & patients
IngrezzaValbenazine Tosylate21$198,582
RexultiBrexpiprazole66$115,689
VraylarCariprazine Hcl75$114,709
AustedoDeutetrabenazine15$93,323
TrintellixVortioxetine Hydrobromide57$34,727
CaplytaLumateperone Tosylate12$22,840
Lurasidone Hcl33$6,558
Desvenlafaxine Succinate ErDesvenlafaxine Succinate108$4,703
Buspirone Hcl200$3,008
Vilazodone Hcl25$2,255
Aripiprazole97$2,185
Duloxetine Hcl89$2,043
Clonazepam238$1,960
Quetiapine Fumarate182$1,863
Amitriptyline Hcl112$1,689

Paid to pharmacies, not to this prescriber.

Companies that both paid and supply prescribed drugs

These companies both reported payments to this provider and make drugs the provider prescribed under Medicare Part D in 2024. For most specialties this overlap is expected — a cardiologist who is paid by a cardiology drugmaker also treats heart disease. It is shown so the reader can see it, not because it implies anything on its own.

CompanyPaid to this providerPart D cost of their drugs
Neurocrine Biosciences, Inc.Ingrezza$653$198,58221 claims
Otsuka America Pharmaceutical, Inc.Rexulti$438$115,68966 claims
AbbVieVraylar$739$114,70975 claims
Teva Pharmaceuticals USA, Inc.Austedo$313$93,32315 claims
Takeda Pharmaceuticals U.S.A., Inc.Trintellix$103$34,72757 claims
ITI, Inc. (d/b/a Intra-cellular Therapies, Inc.)Caplyta$329$22,84012 claims
Lilly USA, LLCOlanzapine$52$94231 claims

Reading this fairly. The Part D column is what drug plans and patients paid pharmacies — this provider received none of it, and it reflects how many patients they treat and what those drugs cost. Against peers, this provider's reported payments sit in the 85th percentile of 1,003 psychiatric/mental health providers in Virginia.

Other psychiatric/mental health in Clintwood

See the full list for Virginia

Where these figures come from

Is this you, or does something look wrong? →